Showing results (51-60 of 134) with videos related to
Sort By:
Pageof 14
Journal of Clinical Microbiology|April 1, 1986
Seroepidemiology of Klebsiella bacteremic isolates and implications for vaccine developmentS J Cryz, P M Mortimer, V Mansfield, et al.Developments in Biological Standardization|January 1, 1996
Factors influencing the stability of live oral attenuated bacterial vaccinesS J Cryz, O Pasteris, S J Varallyay, et al.The Journal of Laboratory and Clinical Medicine|June 1, 1988
Characterization of the human immune response to a Pseudomonas aeruginosa O-polysaccharide-toxin A conjugate vaccineS J Cryz, J C Sadoff, D Ohman, et al.Vaccine|April 1, 1996
Further molecular characterization and stability of the live oral attenuated cholera vaccine strain CVD103-HgRD Favre, M M Struck, S J Cryz, et al.Infection and Immunity|February 1, 1990
Synthesis and characterization of Escherichia coli O18 O-polysaccharide conjugate vaccinesS J Cryz, A S Cross, J C Sadoff, et al.Microbial Pathogenesis|September 1, 1988
A murine monoclonal antibody against Klebsiella capsular polysaccharide is opsonic in vitro and protects against experimental Klebsiella pneumoniae infectionM Trautmann, S J Cryz, J C Sadoff, et al.Vaccine|July 1, 1995
Safety, immunogenicity, and kinetics of the immune response to a single dose of virosome-formulated hepatitis A vaccine in ThaisY Poovorawan, A Theamboonlers, S Chumdermpadetsuk, et al.Infection and Immunity|December 1, 1989
Isolation and characterization of a human monoclonal antibody that recognizes epitopes shared by Pseudomonas aeruginosa immunotype 1, 3, 4, and 6 lipopolysaccharidesA B Lang, E Fürer, J W Larrick, et al.Infectious Disease Clinics of North America|June 1, 1990
Escherichia coli and Klebsiella vaccines and immunotherapyA S Cross, J C Sadoff, E Furer, et al.Vaccine|April 1, 1995
Synthesis and characterization of a polyvalent Escherichia coli O-polysaccharide-toxin A conjugate vaccineS J Cryz, J O Que, A S Cross, et al.Pageof 14